< Return to Video

DavidHeymann 2020S 480p

  • 0:09 - 0:16
    [Applause]
  • 0:24 - 0:30
    this looks like a very mild disease like
  • 0:27 - 0:32
    a common cold in the majority of people
  • 0:30 - 0:35
    there are certain people who get
  • 0:32 - 0:36
    infected and have very serious illness
  • 0:35 - 0:38
    among them are health workers it's a
  • 0:36 - 0:40
    very serious infection in them as they
  • 0:38 - 0:42
    get higher dose than normal people and
  • 0:40 - 0:47
    at the same time they have no immunity
  • 0:42 - 0:49
    so in in the general population it's
  • 0:47 - 0:52
    likely that the dose of virus that you
  • 0:49 - 0:53
    receive when you are infected is much
  • 0:52 - 0:55
    less than the dose that a health worker
  • 0:53 - 0:58
    would receive health workers having more
  • 0:55 - 1:00
    serious infections so your infection
  • 0:58 - 1:02
    would be less serious hopefully so that
  • 1:00 - 1:04
    leaves the elderly and those with
  • 1:02 - 1:07
    comorbidities to really be the ones that
  • 1:04 - 1:10
    we have to make sure are taken care of
  • 1:07 - 1:10
    in hospitals
  • 1:12 - 1:17
    well the most concerned are people who
  • 1:15 - 1:19
    are first of all in developing countries
  • 1:17 - 1:22
    and who don't have access to good
  • 1:19 - 1:25
    medical care and may not have access at
  • 1:22 - 1:27
    all to a hospital should an epidemic
  • 1:25 - 1:29
    occur in their country those people
  • 1:27 - 1:31
    would be a great risk especially the
  • 1:29 - 1:34
    elderly elderly in all populations are
  • 1:31 - 1:36
    at risk but especially those who can't
  • 1:34 - 1:38
    get to oxygen in industrialized
  • 1:36 - 1:41
    countries it's the very elderly who have
  • 1:38 - 1:43
    comorbidities who have diabetes who have
  • 1:41 - 1:45
    other diseases who are at risk the
  • 1:43 - 1:48
    general population doesn't appear to be
  • 1:45 - 1:48
    a great risk
  • 1:50 - 1:55
    first of all pulmonary disease existing
  • 1:53 - 1:58
    as a comorbidity is also important in
  • 1:55 - 2:00
    general the elderly are a greater risk
  • 1:58 - 2:03
    especially those over 70 because their
  • 2:00 - 2:05
    immune systems are not as effective as
  • 2:03 - 2:07
    they might have once been and there are
  • 2:05 - 2:10
    more susceptible to infections in
  • 2:07 - 2:13
    addition in some instances in China
  • 2:10 - 2:15
    there's been a CO infection with
  • 2:13 - 2:17
    influenza and at the same time there
  • 2:15 - 2:19
    have been some bacterial super
  • 2:17 - 2:21
    infections on the pneumonias that are
  • 2:19 - 2:21
    occurring
  • 2:23 - 2:27
    Center for Disease Control in Atlanta
  • 2:24 - 2:30
    keeps track and has updates on a regular
  • 2:27 - 2:32
    basis on its website also the World
  • 2:30 - 2:34
    Health Organization in Geneva which is
  • 2:32 - 2:36
    coordinating many of the activities
  • 2:34 - 2:38
    going on internationally also has a
  • 2:36 - 2:40
    website with daily updates it's our
  • 2:38 - 2:43
    responsibility to get that information
  • 2:40 - 2:45
    as individuals so we understand and can
  • 2:43 - 2:49
    make sure that we can contribute in our
  • 2:45 - 2:49
    own way to prevention of major spread
  • 2:52 - 2:56
    that's the same problem with all new
  • 2:54 - 2:58
    infections this is an infection that's
  • 2:56 - 3:01
    coming to humans who have never been
  • 2:58 - 3:03
    exposed to this virus before they don't
  • 3:01 - 3:05
    have any antibody protection and it's
  • 3:03 - 3:08
    not clear whether their immune system
  • 3:05 - 3:10
    can handle this virus or not this is a
  • 3:08 - 3:13
    virus that usually finds itself in bats
  • 3:10 - 3:15
    or in other animals and all of a sudden
  • 3:13 - 3:17
    it's in humans and humans just don't
  • 3:15 - 3:19
    have experience with this virus but
  • 3:17 - 3:22
    gradually we are beginning to learn a
  • 3:19 - 3:24
    lot as we did with SARS and you know
  • 3:22 - 3:27
    there are certainly a larger number of
  • 3:24 - 3:29
    deaths than there were with SARS but
  • 3:27 - 3:31
    when you divide that by a denominator of
  • 3:29 - 3:33
    persons who are infected there are many
  • 3:31 - 3:36
    many more persons infected than that
  • 3:33 - 3:39
    where with SARS the case fatality ratio
  • 3:36 - 3:41
    that is the ratio of deaths to the
  • 3:39 - 3:44
    numbers of cases in SARS was about 10
  • 3:41 - 3:49
    percent with the current coronavirus
  • 3:44 - 3:51
    Koba 19 is 2 percent or probably less so
  • 3:49 - 3:54
    it's a much less virulent virus but it's
  • 3:51 - 3:55
    still a virus that causes mortality and
  • 3:54 - 3:58
    that's what we don't want
  • 3:55 - 3:58
    entering human populations
  • 4:00 - 4:06
    it's clearly understood that airports or
  • 4:03 - 4:08
    any land borders cannot prevent the
  • 4:06 - 4:10
    disease from entering people in the
  • 4:08 - 4:12
    incubation period can cross that border
  • 4:10 - 4:15
    can enter countries and can then infect
  • 4:12 - 4:18
    others when they become sick so its
  • 4:15 - 4:20
    borders are not a means of preventing
  • 4:18 - 4:23
    infections from entering a country by
  • 4:20 - 4:25
    checking temperatures borders are
  • 4:23 - 4:27
    important because you can provide to
  • 4:25 - 4:29
    people arriving from areas that might be
  • 4:27 - 4:31
    at risk of having had infection
  • 4:29 - 4:33
    providing them with an understanding
  • 4:31 - 4:36
    either a printed understanding or a
  • 4:33 - 4:38
    verbal understanding of what the signs
  • 4:36 - 4:40
    and symptoms are of this infection and
  • 4:38 - 4:43
    what they should do if they feel that
  • 4:40 - 4:43
    they might be infected
  • 4:44 - 4:49
    vaccines are under development right now
  • 4:47 - 4:51
    there's a lot of research going on that
  • 4:49 - 4:54
    research requires first that the vaccine
  • 4:51 - 4:57
    be developed then that it be studied for
  • 4:54 - 4:59
    safety and effectiveness in animals who
  • 4:57 - 5:01
    are challenged with the virus when
  • 4:59 - 5:03
    they're after they're in vaccinated and
  • 5:01 - 5:06
    then it was going to human studies the
  • 5:03 - 5:08
    animal studies have not yet begun but
  • 5:06 - 5:10
    will soon begin for certain vaccines and
  • 5:08 - 5:12
    it's thought that by the end of the year
  • 5:10 - 5:14
    or early next year there may be some
  • 5:12 - 5:17
    candidate vaccines that can then be
  • 5:14 - 5:20
    studied for licensing by regulatory
  • 5:17 - 5:22
    agencies so we're talking about at least
  • 5:20 - 5:27
    a year until there's vaccine available
  • 5:22 - 5:27
    that can be used in many populations
  • 5:29 - 5:33
    that's clear we know how it transmits we
  • 5:31 - 5:37
    don't know how easily it transmits in
  • 5:33 - 5:40
    humans in communities or in unenclosed
  • 5:37 - 5:42
    areas we know and for example they did
  • 5:40 - 5:45
    in the enclosed area of a cruise ship it
  • 5:42 - 5:47
    spread very easily we need to better
  • 5:45 - 5:49
    understand how it will spread once it
  • 5:47 - 5:54
    gets into more open areas where people
  • 5:49 - 5:54
    are exposed to people who might be sick
  • 5:56 - 6:01
    a major problem in the world today is
  • 5:58 - 6:03
    that we look at outbreaks in developing
  • 6:01 - 6:06
    countries there's something that we need
  • 6:03 - 6:08
    to go and stop so when there's an
  • 6:06 - 6:10
    outbreak of Ebola we think how can we go
  • 6:08 - 6:13
    and stop this outbreak because we don't
  • 6:10 - 6:16
    think about how can we help that country
  • 6:13 - 6:19
    strengthen its capacity so that it can
  • 6:16 - 6:22
    detect and respond to infections so we
  • 6:19 - 6:24
    haven't invested enough in helping
  • 6:22 - 6:26
    countries develop their core capacity in
  • 6:24 - 6:29
    public health what we've done is
  • 6:26 - 6:32
    invested in many mechanisms globally
  • 6:29 - 6:34
    which can provide support to other
  • 6:32 - 6:36
    countries to go and help stop outbreaks
  • 6:34 - 6:38
    but we want to see a world where every
  • 6:36 - 6:41
    country can do its best to stop its own
  • 6:38 - 6:41
    outbreaks
  • 6:42 - 6:45
    today there are over seven billion
  • 6:43 - 6:47
    people and when those people come into
  • 6:45 - 6:49
    the world they demand more food they
  • 6:47 - 6:50
    demand a whole series of things and they
  • 6:49 - 6:52
    live closer together
  • 6:50 - 6:55
    in fact we're in an urban world where
  • 6:52 - 6:57
    people live in urban areas and at the
  • 6:55 - 7:00
    same time we're growing more animals and
  • 6:57 - 7:03
    those animals are contributing food to
  • 7:00 - 7:05
    humans as well so what we see is that
  • 7:03 - 7:09
    that animal human interface is becoming
  • 7:05 - 7:11
    closer and closer together and and this
  • 7:09 - 7:14
    intensive agriculture of animals and
  • 7:11 - 7:16
    this intensive increase in human
  • 7:14 - 7:19
    populations living together on the same
  • 7:16 - 7:22
    planet is really a melting pot where
  • 7:19 - 7:24
    outbreaks can occur and do occur we will
  • 7:22 - 7:28
    eventually have more and more of these
  • 7:24 - 7:30
    outbreaks so an emerging infection today
  • 7:28 - 7:32
    is just a warning of what will happen in
  • 7:30 - 7:34
    the future we have to make sure that
  • 7:32 - 7:37
    that technical collaboration in the
  • 7:34 - 7:39
    world is there to work together to make
  • 7:37 - 7:41
    sure that we can understand these
  • 7:39 - 7:43
    outbreaks when they occur and rapidly
  • 7:41 - 7:45
    provide the information necessary to
  • 7:43 - 7:45
    control
  • 7:46 - 7:50
    I can't predict with accuracy so all I
  • 7:48 - 7:54
    can say is that we must all be prepared
  • 7:50 - 7:56
    for the worst-case scenario and at the
  • 7:54 - 7:58
    same time learn how we can protect
  • 7:56 - 8:02
    ourselves and protect others should we
  • 7:58 - 8:02
    become a part of that a together
  • 8:05 - 8:09
    [Music]
  • 8:09 - 8:11
    you
Title:
DavidHeymann 2020S 480p
Video Language:
English
Duration:
08:11

English subtitles

Revisions